June 2026

India's manufacturing footprint is expanding, biosimilars are gaining momentum, and FDA inspections are evolving. The latest U.S. pharmaceutical quality report offers important insights for Indian manufacturers, exporters, regulators, and pharmacy professionals.

Researchers from the University Hospital Bonn (UKB) and the University of Bonn have developed a new laboratory model that enables scientists to generate and study follicular regulatory T (Tfr) cells, a specialized group of immune cells responsible for controlling antibody responses. The breakthrough is expected to accelerate research into autoimmune diseases, vaccine responses, and immune regulation. The findings have been published in the journal Cellular & Molecular Immunology.

Merck KGaA has signed a definitive agreement to acquire U.S.-based life sciences company Bio-Techne in an all-cash transaction valued at approximately USD 11.3 billion (EUR 9.9 billion). The acquisition is expected to significantly strengthen Merck's position in rapidly growing life sciences segments, including multi-omics, spatial biology, precision diagnostics, and cell & gene therapy.